Weight-based dosing of lenvatinib for advanced hepatocellular carcinoma

被引：2
|
作者：
Ogasawara, Sadahisa [1 ,2 ]
Ooka, Yoshihiko [1 ]
Kato, Naoya [1 ,2 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
[2] Chiba Univ Hosp, Translat Res & Dev Ctr, Chiba, Japan
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2020年 / 9卷 / 02期
关键词：
D O I：
10.21037/hbsn.2019.09.21
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [1] Lenvatinib in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2017, 6 (04) : 253 - 263
  • [2] Changing Body Weight-Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma
    Novakovic, Ana M.
    Wilkins, Justin J.
    Dai, Haiqing
    Wade, Janet R.
    Neuteboom, Berend
    Brar, Satjit
    Bello, Carlo L.
    Girard, Pascal
    Khandelwal, Akash
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (03) : 588 - 596
  • [3] Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
    Oikonomopoulos, Georgios
    Aravind, Preetha
    Sarker, Debashis
    FUTURE ONCOLOGY, 2016, 12 (04) : 465 - 476
  • [4] Weighing in on weight-based secukinumab dosing for psoriasis
    Balak, Deepak M. W.
    Lambert, Jo
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (01) : 10 - 11
  • [5] Weight-based dosing of alemtuzumab: an ounce of prevention?
    Augustine, Joshua J.
    TRANSPLANT INTERNATIONAL, 2017, 30 (11) : 1095 - 1097
  • [6] Optimal weight base for a weight-based heparin dosing protocol
    Yee, WP
    Norton, LL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (02) : 159 - 162
  • [7] Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma
    Rehman, Obaid
    Jaferi, Urooj
    Padda, Inderbir
    Khehra, Nimrat
    Atwal, Harshan
    Mossabeh, Dina
    Bhangu, Ranvir
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (03) : 249 - 257
  • [8] Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma
    Miyajima, Saori
    Tsuji, Kunihiro
    Kito, Yosuke
    Yoshida, Naohiro
    Matsunaga, Kazuhiro
    Tsuji, Shigetsugu
    Katayanagi, Kazuyoshi
    Yonezawa, Miwa
    Kubo, Anna
    Ushijima, Kahori
    Minato, Hiroshi
    Doyama, Hisashi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) : 187 - 192
  • [9] Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma
    Hsieh, M-C.
    Su, Y-L.
    Chen, Y-Y.
    Liu, C-T.
    Chen, Y-H.
    Chiu, T-J.
    Pei, S-N.
    Wu, C-C.
    Rau, K-M.
    ANNALS OF ONCOLOGY, 2018, 29 : 57 - 57
  • [10] Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
    Ikeda, Masafumi
    Okusaka, Takuji
    Mitsunaga, Shuichi
    Ueno, Hideki
    Tamai, Toshiyuki
    Suzuki, Takuya
    Hayato, Seiichi
    Kadowaki, Tadashi
    Okita, Kiwamu
    Kumada, Hiromitsu
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1385 - 1394
12345